RET-IN-36
RET-IN-36 is an orally active RET kinase inhibitor. RET-IN-36 overcomes gatekeeper and solvent front resistance mutations and inhibits the proliferation of cells expressing RETG810C and RETV804M mutants by suppressing RET phosphorylation and SHC downstream signaling. RET-IN-36 can be used for research on RET-mutant cancers, medullary thyroid cancer, papillary thyroid cancer, and non-small cell lung cancer.
For research use only. We do not sell to patients.
- Formula: C33H32FN7O2
- Molecular Weight:577.65
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| BaF3 | IC50 |
0.0208 μM
|
Antiproliferative activity against BaF3 cells stably expressing CCDC6-RETV804M assessed as reduction in cell proliferation incubated for 72 hrs by Cell Counting Kit 8 assay.
Antiproliferative activity against BaF3 cells stably expressing CCDC6-RETV804M assessed as reduction in cell proliferation incubated for 72 hrs by Cell Counting Kit 8 assay.
|
42607442 |
| BaF3 | IC50 |
0.096 μM
|
Antiproliferative activity against BaF3 cells stably expressing CCDC6-RETG810C assessed as reduction in cell proliferation incubated for 72 hrs by Cell Counting Kit 8 assay.
Antiproliferative activity against BaF3 cells stably expressing CCDC6-RETG810C assessed as reduction in cell proliferation incubated for 72 hrs by Cell Counting Kit 8 assay.
|
42607442 |
In Vitro
RET-IN-36 (compound 11ic) (0.0005-10 μM; 72 h) inhibits the proliferation of BaF3-CCDC6-RETG810C and BaF3-CCDC6-RETV804M cells[1].
RET-IN-36 (3-300 nM; 6 h) inhibits RET signaling in BaF3-CCDC6-RETG810C cells[1].
RET-IN-36 (72 h) effectively inhibits the proliferation of BaF3 cells expressing CCDC6-RETV804M and CCDC6-RETG810C, with IC50 values of 0.0208 μM and 0.096 μM, respectively[1].
RET-IN-36 (0.3 μM; 6 h) dose-dependently inhibits RET activation and downstream signaling through SHC in BaF3-CCDC6-RETG810C cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:BaF3-CCDC6-RETG810C cells
-
Concentration:3, 10, 30, 100, 300 nM
-
Incubation Time:6 h
-
Result:Inhibited RET signaling in BaF3-CCDC6-RETG810C cells.
-
Cell Line:BaF3 cells expressing CCDC6-RETG810C
-
Concentration:0.3 μM
-
Incubation Time:6 h
-
Result:Inhibited RET phosphorylation and downstream signaling through SHC at 0.3 μM.
Parmacokinetics
Chemical Information
-
Molecular Weight 577.65
-
Formula C33H32FN7O2
-
SMILES
FC1=C(N2C=CC(NC3=NC(N([C@@H]4CCCN(C(C5CC5)=O)C4)C(C(C6=C(C)C=CC=C6)=C7C)=O)=C7C=N3)=N2)C=CC=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
RET-IN-36 Related Classifications
HY-189268 Related Classifications
Powered by Bioz